Rezultati pretraživanja
  1. 2. sij 2013.

    All about . Tagged on

  2. 11. ruj 2019.

    Our experts are looking forward to discussing with you new perspective on at the Weimar . Visit us at booth 29 -ADM®

  3. 27. stu 2018.

    : Adrenomed closes €24 mln Series D round to complete proof-of-concept trial of antibody for septic shock. see .com

  4. 25. ruj 2019.

    Dr. Frauke Hein, CBO of , will give a “Spotlight Talk on Sepsis” today at the in . Discover the latest knowledge on and ’s role in tackling this awful disease by restoring

  5. 27. stu 2018.

    reports the great news of from HBM and Wellington to execute proof-of-concept trial of lead product candidate in early

  6. 18. ruj 2019.

    ! Next week, our CBO Frauke Hein will participate in , and in , . Many chances to meet and to discuss how tackles by restoring

  7. 12. stu 2019.

    Today, our CBO, Dr. Hein, will give a presentation at , 11:15 AM, Level 1/Hall B1/Room 6 🎤👩‍🏫. Join and discover how tackles by restoring with its first-in-class

  8. Berlin Biotech Raises €24M to Progress Septic Shock Candidate to Clinic

  9. 26. stu 2018.

    raises € 24 M in round led by Wellington and HBM. The new funds will be used to execute a proof-of-concept clinical program of lead product candidate in early

  10. 9. svi 2017.
  11. 11. pro 2017.

    Adrenomed Doses First Patient in Proof-of-Concept Phase 2 Study with Adrecizumab

  12. 2. sij 2013.

    creates to decrease death rates from sepsis: |

  13. 27. stu 2018.

    is a life-threatening condition affecting millions of people worldwide with a remaining high mortality rate of approximately 30-50% BUT may be one step closer to treating the condition.

  14. 26. ruj 2019.

    announces the successful completion of enrollment in the 300-patient PoC Phase II trial, AdrenOSS-2. “By restoring , we aim to provide physicians with a new therapy for patients,” said Dr. Andreas Bergmann, CSO

  15. 15. lip 2018.
  16. 30. kol 2019.
  17. 27. stu 2018.

    In einer Serie D-Runde konnte die Hennigsdorfer AG neues einsammeln. Neue Investoren sind Wellington Partners und HBM Healthcare Investments.

  18. 26. stu 2018.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.